FDA seeks input on proposed predecisional process for device trials

06/20/2013 | Clinica (subscription required)

The FDA has released draft guidance governing a new voluntary program that would help clinical trial sponsors assess, prior to submitting an investigational device exemption application, whether the design of their pivotal study would lead to marketing approval. The guidance is up for comment through Sept. 12.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ